PHARMAIDS PHARMACEUTICALS

BSE: 524572 28 Jun 2025

Healthcare

₹ 56.37

Pharmaids Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

PHARMAIDS PHARMACEUTICALS

BSE: 524572 28 Jun 2025

Healthcare

₹ 56.37

Pharmaids Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

18.1

Dividend Yield

0.0%

Debt to Equity

0.62

Stock P/E

Market Cap

204.0 Cr

PHARMAIDS PHARMACEUTICALS - Share Price & Details

Market Cap

₹204.0

High /Low

87.5 / 31.9

Stock P/E

Book Value

₹18.1

Dividend Yield

0.0

ROCE

-6.87

ROE

₹-10.8

Face Value

10.0

PEG Ratio

EVEBITDA

₹-39.0

Debt

39.7

CMP / FCF

-14.5

Debt to equity

₹0.62

NP Ann

-7.28

High price all time

87.5

Piotroski score

₹4.0

Graham Number

No. Eq. Shares

3.53

Net CF

₹-1.99

Net profit

-7.28

Price to book value

3.2

Interest Coverage

₹-3.0

Low price all time

1.58

Industry PE

33.8

Reserves

₹28.5

Free Cash Flow

₹-16.8

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
LOOKS HEALTH SERVICES LIMITED	NA	NA	NA	NA	5.11	256.0
Triochem Products Ltd.,	NA	NA	NA	NA	0
PHARMAIDS PHARMACEUTICALS LTD.	NA	NA	NA	NA	204.0
SYSCHEM (INDIA) LTD.	NA	NA	NA	NA	201	437.0
PANCHSHEEL ORGANICS LTD.	NA	NA	NA	NA	197	14.3

Peer Comparison Chart

About PHARMAIDS PHARMACEUTICALS

Pharmaids Pharmaceuticals Ltd., with Security Code 524572, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Pharmaids Pharmaceuticals Faces Mixed Financial Signals Amid Growth and Challenges

(29 May 2025)

Pharmaids Pharmaceuticals has recently adjusted its evaluation, reflecting a mix of growth and challenges in its financial metrics.

Camlin Fine Sciences reports consolidated net loss of Rs 0.72 crore in the March 2025 quarter

(28 May 2025)

Sales rise 16.14% to Rs 437.46 crore.

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 3.94 crore in the March 2025 quarter

(25 May 2025)

Sales decline 17.90% to Rs 4.77 crore. Net Loss of Pharmaids Pharmaceuticals reported to Rs 3.94 crore in the quarter ended March 2025 as against net loss...

Pharmaids Pharmaceuticals Reports Mixed Financial Results Amidst Rising Costs and Strong Sales Growth in March 2025

(24 May 2025)

Pharmaids Pharmaceuticals has announced its financial results for the quarter ending March 2025, showing net sales of Rs 9.48 crore, a year-on-year growth...

Krishna Capital & Securities consolidated net profit declines 45.45% in the March 2025 quarter

(24 May 2025)

Sales rise 90.91% to Rs 0.21 crore. Net profit of Krishna Capital & Securities declined 45.45% to Rs 0.06 crore in the quarter ended March 2025 as against...

Q4 results today: JSW Steel, Ashok Leyland, Glenmark Pharma on May 23

(23 May 2025)

Q4 results today, May 23, 2025: Reliance Infrastructure, Afcons and Narayana Hrudayalaya will be among 202 companies to post earnings...

Quarterly Table

Standalone Consolidated

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	1.2
Expenses	0.5	0.7	8.6	1.6	1.0	1.3	1.8	1.9	2.0	2.9
Operating Profit	-0.5	-0.7	-8.6	-1.6	-1.0	-1.3	-1.8	-1.7	-1.1	-1.7
OPM %	0%	0%	0%	0%	0%	-6166.67%	-25814.29%	-1027.54%	-135.37%	-143.13%
Other Income	0.0	0.0	0.0	0.4	-0.3	-0.9	0.0	0.0	0.0	0.0
Interest	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
Depreciation	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1
Profit before tax	-0.5	-0.7	-8.6	-1.2	-1.3	-2.2	-2.1	-1.8	-1.2	-1.8
Tax %	0.7%	0.4%	-28.4%	7.8%	-60.8%	-26.1%	6.1%	-8.5%	-15.2%	-13.7%
Net Profit	-0.5	-0.7	-6.2	-1.3	-0.5	-1.6	-2.2	-1.6	-1.0	-1.6
EPS in Rs	0	-0.5	-4.79	-0.58	-0.23	-0.73	-0.99	-0.46	-0.29	-0.45

Metrics	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	0.0	0.0	0.0	0.0	5.8	4.7	5.2	4.7
Expenses	8.6	1.6	1.0	1.3	11.4	8.1	7.8	7.6
Operating Profit	-8.6	-1.6	-1.0	-1.3	-5.6	-3.4	-2.6	-2.9
OPM %	0%	0%	0%	-6166.67%	-96.09%	-72.88%	-48.81%	-61.27%
Other Income	0.0	0.4	-0.3	-0.9	0.1	-0.1	-0.1	0.0
Interest	0.0	0.0	0.0	0.0	0.8	0.3	0.3	0.5
Depreciation	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.6
Profit before tax	-8.6	-1.2	-1.3	-2.2	-6.9	-4.2	-3.5	-4.0
Tax %	-28.4%	7.8%	-60.8%	-26.1%	-7.8%	-27.4%	-28.1%	-24.9%
Net Profit	-6.2	-1.3	-0.5	-1.6	-6.3	-3.1	-2.6	-3.0
EPS in Rs	-4.76	-0.58	-0.23	-0.73	-2.82	-0.76	-0.73	-0.55

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	-32%
5 Years:	-44%
3 Years:	-85%
TTM:	11000%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	29%

Stock Price CAGR
10 Years:	32%
5 Years:	67%
3 Years:	77%
1 Year:	11%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	102050%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	-34%

Stock Price CAGR
10 Years:	32%
5 Years:	67%
3 Years:	77%
1 Year:	11%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

PHARMAIDS PHARMACEUTICALS

PHARMAIDS PHARMACEUTICALS

PHARMAIDS PHARMACEUTICALS - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About PHARMAIDS PHARMACEUTICALS

Latest News

Pharmaids Pharmaceuticals Faces Mixed Financial Signals Amid Growth and Challenges

Camlin Fine Sciences reports consolidated net loss of Rs 0.72 crore in the March 2025 quarter

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 3.94 crore in the March 2025 quarter

Pharmaids Pharmaceuticals Reports Mixed Financial Results Amidst Rising Costs and Strong Sales Growth in March 2025

Krishna Capital & Securities consolidated net profit declines 45.45% in the March 2025 quarter

Q4 results today: JSW Steel, Ashok Leyland, Glenmark Pharma on May 23

Q4 results today: JSW Steel, Ashok Leyland, Glenmark & others to declare earnings on May 23 — Full list here

Q4 results: JSW Steel, Aditya Birla Fashion, Ashok Leyland, Ashoka Buildcon, Reliance Infra and others to declare earnings today; check list

Pharmaids Pharmaceuticals Adjusts Evaluation Amid Mixed Performance Indicators and Challenges

Pharmaids Pharmaceuticals Faces Stability Amidst Operating Challenges and Debt Concerns

Briefs: AstraZeneca Pharma India, Pharmaids and Dr. Agarwal's Health Care

Prima Plastics consolidated net profit declines 51.04% in the December 2024 quarter

Q3 Results Today: HAL, PFC, RFC, Godrej Industries Among 500 Firms To Declare Earnings

Shankarappa Nagaraja Vinaya Babu proposed to acquire 26% stake in Pharmaids Pharmaceuticals Limited for approximately INR 570 million.

Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

Pharmaids Pharma Reports Positive Q2 Results, Operating Cash Flow Declines

Emcure and MS Dhoni drive India’s fight against Anemia

Shares below Rs 100: Only buyers were seen in these stocks on November 19

Pharma industry expo to held from Nov 26 to 28 in Greater Noida

NBCC, Deepak Nitrite, Eicher Motors, Patel Engineering Among 650+ Companies To Declare Q2 Results Today

Pharmaids Pharmaceuticals' Stock Reaches All-Time High, Outperforms Sector and Sensex

Pharmaids Pharmaceuticals' Stock Surges to 52-Week High, Outperforming Sector by 4.88%

Pharmaids Pharmaceuticals Hits 52-Week High, Outperforms Sector and Sensex

Pharmaids Pharmaceuticals Surges to All-Time High, Outperforms Sector and Sensex

Shares below Rs 100: Only buyers were seen in these stocks on November 05

Shares below Rs 100: Only buyers were seen in these stocks on November 04

गिरते बाजार में मालामाल कर गए 100 रुपए के ये 5 स्टॉक, क्या कल मिलेगा मौका?

Shares below Rs 100: Only buyers were seen in these stocks on October 31

Shares below Rs 100: Only buyers were seen in these stocks on October 30

Pharmaids Pharmaceuticals Hits 52-Week Low with Strong Sell Rating from MarketsMOJO

Pharmaids Pharmaceuticals Hits 52-Week Low, Receives 'Strong Sell' Rating from MarketsMOJO

Pharmaids Pharmaceuticals secures ₹5 crore loan from related party

Stock Market Live Updates September 13, 2024: Sensex, Nifty give up early gains to trade flat at mid-session; Wipro, Bajaj twins spurt up

Share Market Highlights September 13, 2024: Sensex, Nifty settle marginally lower on profit-taking

फार्मेड्स फार्मासियुटिकल्स लिमिटेड शेयर प्राइस

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.68 crore in the June 2024 quarter

Stocks to Watch Today, August 12: Adani Group, IIFL,PNB,ONGC, Berger Paints

Q4 Results Today: IRCTC, Aditya Birla Fashion, GIC Among 440+ Companies To Report Earnings

Small stocks are racing ahead, but beware the risks | Stock Market News

Aarey Drugs & Pharmaceuticals Share Price

Oxygenta Pharmaceutical Share Price

Source Natural Foods & Herbal Supplements Share Price

Buzzing Stocks: NTPC, Godrej Properties, SJVN, Park Hotels, Avenue Supermarts, others in news

Aster DM hits record high as arm acquires 20.40% stake in Aasraya Healthcare

Pharmaids Pharmaceuticals acquires 50.60% stake in Anugraha Chemicals

Live market news, research and portfolio

PHARMAIDS PHARMACEUTICALS ACQUIRES 50 60PERCENT STAKE IN ANUGRAHA CHEMICALS

Stocks that will see action today: January 8, 2024

Pharmaids Pharmaceuticals to acquire Adita Bio Sys in share swap

Amrutanjan Health Care shares rally 12 per cent on buyback proposal

Zydus Lifesciences gets USFDA nod to its generic medicine for high BP

Pharmaids Pharmaceuticals Ltd Share Price Today, Stock Price BSE

Pharmaids Pharmaceuticals to Acquire Majority Stake in Anugraha Chemicals

Shares below Rs 100: Only buyers were seen in these stocks on December 08!

Alembic gets USFDA nod for cancer treatment drug

Buzzing Stocks: Shree Cement, JSW Steel, United Spirits and others that will be in focus today

Trimurthi Drugs & Pharmaceuticals consolidated net profit declines 33.33% in the June 2015 quarter

Quarterly Table

Shareholding Distribution

Shareholding Pattern

Compounded Data

All Deals

Select Date

Stock Mutual Funds Data